Month: September 2024

WOBURN, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, announces its partnership with Product Genius Technology, a leading provider of innovative solutions in the fastener industry. Bridgeline’s HawkSearch AI technology will leverage the solutions provider’s technology to enhance customer engagement and drive sales within the fastener eCommerce sector. The partnership will allow HawkSearch to be the first to market with the patented Product Genius Technology™, an application that simplifies the search, sort, and display of complex product categories, such as fasteners. HawkSearch is a recognized leader in site search technology, offering tailored AI solutions that help customers find the right results. Together, the partners aim to increase...

As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) MARLBOROUGH, Mass., BERLIN, Germany, and YOKNEAM ILLIT, Israel, Sept. 05, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (DBA Lifeward™) (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, is pleased to announce the successful completion of the first ReWalk Step Challenge 2024. This unique charity initiative brought together the community of ReWalk Personal Exoskeleton users in Germany with the aim of completing as many steps as possible in their ReWalk Exoskeleton...

ATLANTA, Sept. 05, 2024 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces that the Company will be exhibiting at the Canadian Fertility and Andrology Society’s (CFAS) 70th Annual Meeting, to be held September 12-14, 2024 at The Westin Bayshore, Vancouver, British Columbia. The Company will be exhibiting at Booth #S26. Kathy-Lee Sepsick, Femasys Founder and CEO commented, “This is an important opportunity to connect with practitioners whose patients and clients would benefit from our suite of products. The conference comes at a particularly opportune moment as we recently announced the Canadian approval of FemVue MINI, our eco-friendly...

Strategic Alliance Set to Transform Fashion, Sports, Lifestyle, and Retail Industries Through AI-Driven Innovation NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) — Rezolve AI (Nasdaq: RZLV), a global leader in artificial intelligence solutions, proudly announces a partnership with SPH AG, a leading IT and consulting company renowned for its digitalization and ERP expertise in the fashion, sports, lifestyle, and retail sectors. This alliance is poised to redefine the future of these industries through the deployment of Rezolve’s proprietary AI technologies, including BRAiN Commerce, BRAiN Checkout, and BRAiN Assistant. Unleashing the Power of AI to Drive Business TransformationRezolve AI’s partnership with SPH AG is more than a collaboration; it’s a convergence of advanced AI technology and deep industry knowledge....

Robert “Bob” PetrocelliVimeo’s newly announced Chief Product & Technology OfficerNEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) — Vimeo (NASDAQ: VMEO), the world’s most innovative video experience platform for creators and enterprises, today announced the appointment of technology veteran Robert (“Bob”) Petrocelli as Chief Product & Technology Officer, effective September 9, 2024. Bob will be responsible for leading Vimeo’s global product and engineering teams as the company continues to propel technology innovation, deliver high-quality video experiences, and maximize customer value for businesses, creators and video pros around the world. “As we ramp up investment in innovation and continue positioning Vimeo to power the future of video, bolstering our technology leadership is key. Bringing...

Demonstrating ability to deliver chemical-free cleaning solutions to education sector Omaha, NE, Sept. 05, 2024 (GLOBE NEWSWIRE) — CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of patented technology that works as a safe and low-cost replacement for traditional cleaning chemicals, announced today that it has successfully installed over 200 of its patented cleaning systems on the premise of a large and recognizable university located in the western United States. This installation began with a successful pilot program of 30 units of the Company’s products, and CleanCore’s contracts include training and support for employees. The large university has implemented initiatives to become a chemical-free campus, and as a result of those initiatives, during the past 60 days, CleanCore has fulfilled...

Collaboration with World Leading University, University of Edinburgh Multi-Million Dollar Transformative Project for Long-Term Care Future Partnering OpportunitiesVANCOUVER, British Columbia, Sept. 05, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with the University Court of the University of Edinburgh (“University of Edinburgh”). The University of Edinburgh is looking to utilize Treatment’s proprietary Global Library of Medicine (“GLM”) to jointly build applications within the “SET4 Systems Engineering to Transform Transitions In Health and Social Care innovation initiative” (“SET4”). World Leading University Treatment is partnering with the University of Edinburgh, recently acknowledged as amongst the world’s...

BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the appointment of Julie Eastland, an experienced biotechnology and financial executive, to Lantheus’ Board of Directors (“Board”), effective as of September 3, 2024. As an independent director, Ms. Eastland will serve as a member of the Board’s Audit Committee. Following the appointment of Ms. Eastland, the Board will be comprised of ten directors, eight of whom are independent. “We are thrilled to welcome Julie Eastland to the Lantheus Board of Directors. Ms. Eastland’s extensive biotechnology expertise across finance, strategic planning, operations and transactions...

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its progress toward completion of the clinical study plan required for its FDA 510(k) submission. In August 2024, INBS announced its partnership with CenExel to perform the method comparison study as part of the Company’s clinical study plan. The study involves the recruitment of 135 healthy adult subjects across three sites under an IRB-approved protocol and comparing the results of fingerprint sweat opiate screening tests with those obtained using a validated, traceable liquid chromatography-mass spectrometry (LC-MS/MS) method in a laboratory. The Company has successfully completed...